Kailera Therapeutics

KLRANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.418 B

$18.66 -1.11%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

129,565,608

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#94PharvarisPHVS$2.43B
#95Viridian Therapeutics, Inc.\DEVRDN$2.43B
#96Kailera TherapeuticsKLRA$2.42B
#97Vera TherapeuticsVERA$2.36B
#98Bausch Health CompaniesBHC$2.34B

Where these numbers come from

Share counts and financials for Kailera Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.